Showing results (81-90 of 336) with videos related to
Sort By:
Pageof 34
Orphanet Journal of Rare Diseases|November 16, 2019
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centersHanny Al-Samkari, Hasan A Albitar, Scott E Olitsky, et al.Blood Advances|September 9, 2021
Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndromeAndrew B Song, Rahul Sakhuja, Nancy M Gracin, et al.British Journal of Haematology|February 18, 2022
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US studyHanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, et al.European Journal of Haematology|November 16, 2019
The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patientsJohnny Cai, Jessica Ribkoff, Sven Olson, et al.Journal of Medical Genetics|October 6, 2018
Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the <i>PRF1A91V</i> gene polymorphismHanny Al-Samkari, Gregory D Snyder, Sarah Nikiforow, et al.Blood Advances|March 27, 2024
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasiaDaniel Wang, Satoko Ito, Christina Waldron, et al.Pediatric Emergency Care|April 30, 2020
Utility of Blood Cultures and Empiric Antibiotics in Febrile Pediatric Hemophilia Patients With Central Venous Access DevicesHanny Al-Samkari, Al Ozonoff, Assaf Landschaft, et al.Journal of Thrombosis and Haemostasis : JTH|October 12, 2023
Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and MalignancyGerald Soff, Avi Leader, Hanny Al-Samkari, et al.Pageof 34